Wen Wei

917 total citations
21 papers, 551 citations indexed

About

Wen Wei is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Wen Wei has authored 21 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Wen Wei's work include Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Risks and Factors (2 papers). Wen Wei is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Cancer Risks and Factors (2 papers). Wen Wei collaborates with scholars based in China and Taiwan. Wen Wei's co-authors include Shan Zhu, Juanjuan Li, Shengrong Sun, Chuang Chen, Qi Wu, Juan Wu, Yimin Zhang, Qian Liu, Yi Tu and Chuang Chen and has published in prestigious journals such as IEEE Transactions on Biomedical Engineering, Oncotarget and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Wen Wei

21 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Wei China 13 262 202 166 111 86 21 551
F. De Vita Italy 11 405 1.5× 220 1.1× 198 1.2× 196 1.8× 85 1.0× 37 691
Tessa G. Steenbruggen Netherlands 13 279 1.1× 256 1.3× 127 0.8× 170 1.5× 51 0.6× 24 524
Samanta Sarti Italy 17 490 1.9× 209 1.0× 205 1.2× 193 1.7× 88 1.0× 46 803
Wenbin Huang China 12 139 0.5× 157 0.8× 274 1.7× 129 1.2× 112 1.3× 37 634
Michiko Imamura Japan 17 367 1.4× 196 1.0× 167 1.0× 87 0.8× 90 1.0× 36 653
Christine Gennigens Belgium 13 171 0.7× 77 0.4× 146 0.9× 98 0.9× 62 0.7× 55 530
Marco Puzzoni Italy 16 438 1.7× 159 0.8× 213 1.3× 174 1.6× 38 0.4× 50 737
Alexander Meisel Switzerland 12 183 0.7× 88 0.4× 147 0.9× 102 0.9× 96 1.1× 27 486

Countries citing papers authored by Wen Wei

Since Specialization
Citations

This map shows the geographic impact of Wen Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Wei more than expected).

Fields of papers citing papers by Wen Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Wei. The network helps show where Wen Wei may publish in the future.

Co-authorship network of co-authors of Wen Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Wei. A scholar is included among the top collaborators of Wen Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Wei. Wen Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Xin, et al.. (2022). Identification of UCP1 and UCP2 as Potential Prognostic Markers in Breast Cancer: A Study Based on Immunohistochemical Analysis and Bioinformatics. Frontiers in Cell and Developmental Biology. 10. 891731–891731. 15 indexed citations
2.
Wei, Wen, et al.. (2022). Low CRIM1 Levels Predict Poor Prognosis in Breast Cancer Patients. Frontiers in Oncology. 12. 882328–882328. 1 indexed citations
3.
Wang, Yuan, Yulin Xu, Shichong Liao, et al.. (2022). Interleukin‐22 Deficiency Reduces Angiotensin II‐Induced Aortic Dissection and Abdominal Aortic Aneurysm in ApoE‐/‐ Mice. Oxidative Medicine and Cellular Longevity. 2022(1). 7555492–7555492. 1 indexed citations
4.
Zhu, Shan, Yulin Xu, Lijun Wang, et al.. (2021). Ceramide kinase mediates intrinsic resistance and inferior response to chemotherapy in triple‐negative breast cancer by upregulating Ras/ERK and PI3K/Akt pathways. Cancer Cell International. 21(1). 42–42. 19 indexed citations
5.
Wang, Yuan, Shan Zhu, Wen Wei, et al.. (2020). Interleukin-6 knockout reverses macrophage differentiation imbalance and alleviates cardiac dysfunction in aging mice. Aging. 12(20). 20184–20197. 12 indexed citations
6.
Xu, Yulin, Shichong Liao, Lijun Wang, et al.. (2020). Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin. Cancer Chemotherapy and Pharmacology. 87(1). 85–93. 13 indexed citations
7.
8.
Zhu, Shan, Yuan Wang, Hongtao Liu, et al.. (2019). Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-κB p65 Pathway Both In Vitro and In Vivo. Mediators of Inflammation. 2019. 1–10. 13 indexed citations
9.
10.
Wu, Qi, Juanjuan Li, Shan Zhu, et al.. (2017). Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 8(17). 27990–27996. 246 indexed citations
11.
Wu, Qi, Juanjuan Li, Shan Zhu, et al.. (2016). Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype. Oncotarget. 7(52). 87532–87542. 13 indexed citations
12.
Chen, Chuang, Si Sun, Jingping Yuan, et al.. (2016). Characteristics of breast cancer in Central China, literature review and comparison with USA. The Breast. 30. 208–213. 42 indexed citations
13.
Wu, Qi, Juanjuan Li, Si Sun, et al.. (2016). Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes. Oncotarget. 8(2). 2361–2371. 9 indexed citations
14.
Wu, Qi, Yimin Zhang, Si Sun, et al.. (2016). Clinical and sonographic assessment of cervical lymph node metastasis in papillary thyroid carcinoma. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(6). 823–827. 9 indexed citations
15.
Chen, Chuang, Wen Wei, Hongmei Zheng, et al.. (2015). Associations and indications of Ki67 expression with clinicopathological parameters and molecular subtypes in invasive breast cancer: A population-based study. Oncology Letters. 10(3). 1741–1748. 18 indexed citations
16.
17.
Chieh, Jen-Jie, et al.. (2015). Immunomagnetic Reduction Assay on Des-Gamma-Carboxy Prothrombin for Screening of Hepatocellular Carcinoma. IEEE Transactions on Biomedical Engineering. 63(8). 1681–1686. 9 indexed citations
18.
Zhang, Yimin, Shichong Liao, Wei Fan, et al.. (2014). Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells. Oncology Reports. 32(6). 2769–2776. 18 indexed citations
19.
Yao, Feng, et al.. (2012). Sonographically Guided Vacuum-Assisted Breast Biopsy for Complete Excision of Presumed Benign Breast Lesions. Journal of Ultrasound in Medicine. 31(12). 1951–1957. 21 indexed citations
20.
Peng, Hao, et al.. (2009). [Comparison of microendoscopic discectomy with open discectomy for degenerative lumbar spinal stenosis].. PubMed. 23(10). 1200–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. De Vita Breakdown of academic impact, for papers by Tessa G. Steenbruggen Breakdown of academic impact, for papers by Samanta Sarti Breakdown of academic impact, for papers by Wenbin Huang Breakdown of academic impact, for papers by Michiko Imamura Breakdown of academic impact, for papers by Christine Gennigens Breakdown of academic impact, for papers by Marco Puzzoni Breakdown of academic impact, for papers by Alexander Meisel
Rankless by CCL
2026